Android app on Google Play

Ventrus Biosciences (VTUS) IPO Prices at $6

December 17, 2010 9:39 AM EST Send to a Friend
Get Alerts VTUS Hot Sheet
Trade VTUS Now!
Join SI Premium – FREE
Ventrus Biosciences Inc. (Nasdaq: VTUS) prices its IPO of 2,900,000 shares at $6.00 per share, the low end of the expected $6-$7 range. The shares will open today on the Nasdaq Capital Market under the symbol "VTUS."

Rodman & Renshaw, LLC, and National Securities Corporation acted as co-lead managing underwriters for the offering.

Ventrus is a development stage specialty pharmaceutical company focused on the development of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence.




You May Also Be Interested In


Related Categories

IPOs, Trader Talk

Related Entities

Rodman & Renshaw

Add Your Comment